| Dr Luis Roberto Gonzalez, MD | |
|
21 Montauk Ave, New London, CT 06320-4906 | |
| (860) 439-6400 | |
| Not Available |
| Full Name | Dr Luis Roberto Gonzalez |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 48 Years |
| Location | 21 Montauk Ave, New London, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801863220 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 24882 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bhcare, Inc. | 5193819308 | 26 |
| Intercommunity Inc | 9032001649 | 29 |
| Prospect Manchester Hospital, Inc. | 9234423625 | 16 |
| Sound Community Services Inc | 7517981517 | 9 |
| Cooley Dickinson Hospital Inc | 8123090560 | 37 |
News Archive
Alcoholism is a tough addiction to kick. Eventually, most people return to drinking. But some Dutch and German psychological scientists have tested a short-term regime that promises to help alcoholics stay sober. Their study is published in Psychological Science, a journal of the Association of Psychological Science.
A new study shows that concern about infertility resulting from breast cancer therapy influenced treatment decisions in nearly one-third of young patients.
Today's headlines hint that summer's almost over, but the heat will still be on for health reform.
Early testing of an experimental human monoclonal antibody showed a striking benefit in patients with advanced melanoma, say researchers at The University of Texas M. D. Anderson Cancer Center, who presented their findings at the annual meeting of the American Society of Clinical Oncology.
Auspex Pharmaceuticals announced today that the first patient has been enrolled in a multi-center Phase 3 pivotal trial of its lead investigational drug, SD-809 for the treatment of involuntary movements (chorea) associated with Huntington's Disease.
› Verified 4 days ago
| Entity Name | Trinity Health Of New England Provider Network Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003882812 PECOS PAC ID: 0941113567 Enrollment ID: O20031110000651 |
News Archive
Alcoholism is a tough addiction to kick. Eventually, most people return to drinking. But some Dutch and German psychological scientists have tested a short-term regime that promises to help alcoholics stay sober. Their study is published in Psychological Science, a journal of the Association of Psychological Science.
A new study shows that concern about infertility resulting from breast cancer therapy influenced treatment decisions in nearly one-third of young patients.
Today's headlines hint that summer's almost over, but the heat will still be on for health reform.
Early testing of an experimental human monoclonal antibody showed a striking benefit in patients with advanced melanoma, say researchers at The University of Texas M. D. Anderson Cancer Center, who presented their findings at the annual meeting of the American Society of Clinical Oncology.
Auspex Pharmaceuticals announced today that the first patient has been enrolled in a multi-center Phase 3 pivotal trial of its lead investigational drug, SD-809 for the treatment of involuntary movements (chorea) associated with Huntington's Disease.
› Verified 4 days ago
| Entity Name | The Charlotte Hungerford Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629075734 PECOS PAC ID: 4486557501 Enrollment ID: O20040128000183 |
News Archive
Alcoholism is a tough addiction to kick. Eventually, most people return to drinking. But some Dutch and German psychological scientists have tested a short-term regime that promises to help alcoholics stay sober. Their study is published in Psychological Science, a journal of the Association of Psychological Science.
A new study shows that concern about infertility resulting from breast cancer therapy influenced treatment decisions in nearly one-third of young patients.
Today's headlines hint that summer's almost over, but the heat will still be on for health reform.
Early testing of an experimental human monoclonal antibody showed a striking benefit in patients with advanced melanoma, say researchers at The University of Texas M. D. Anderson Cancer Center, who presented their findings at the annual meeting of the American Society of Clinical Oncology.
Auspex Pharmaceuticals announced today that the first patient has been enrolled in a multi-center Phase 3 pivotal trial of its lead investigational drug, SD-809 for the treatment of involuntary movements (chorea) associated with Huntington's Disease.
› Verified 4 days ago
| Entity Name | State Of Connecticut |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245256247 PECOS PAC ID: 8022915677 Enrollment ID: O20040319000535 |
News Archive
Alcoholism is a tough addiction to kick. Eventually, most people return to drinking. But some Dutch and German psychological scientists have tested a short-term regime that promises to help alcoholics stay sober. Their study is published in Psychological Science, a journal of the Association of Psychological Science.
A new study shows that concern about infertility resulting from breast cancer therapy influenced treatment decisions in nearly one-third of young patients.
Today's headlines hint that summer's almost over, but the heat will still be on for health reform.
Early testing of an experimental human monoclonal antibody showed a striking benefit in patients with advanced melanoma, say researchers at The University of Texas M. D. Anderson Cancer Center, who presented their findings at the annual meeting of the American Society of Clinical Oncology.
Auspex Pharmaceuticals announced today that the first patient has been enrolled in a multi-center Phase 3 pivotal trial of its lead investigational drug, SD-809 for the treatment of involuntary movements (chorea) associated with Huntington's Disease.
› Verified 4 days ago
| Entity Name | Intercommunity Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073548533 PECOS PAC ID: 9032001649 Enrollment ID: O20040329000218 |
News Archive
Alcoholism is a tough addiction to kick. Eventually, most people return to drinking. But some Dutch and German psychological scientists have tested a short-term regime that promises to help alcoholics stay sober. Their study is published in Psychological Science, a journal of the Association of Psychological Science.
A new study shows that concern about infertility resulting from breast cancer therapy influenced treatment decisions in nearly one-third of young patients.
Today's headlines hint that summer's almost over, but the heat will still be on for health reform.
Early testing of an experimental human monoclonal antibody showed a striking benefit in patients with advanced melanoma, say researchers at The University of Texas M. D. Anderson Cancer Center, who presented their findings at the annual meeting of the American Society of Clinical Oncology.
Auspex Pharmaceuticals announced today that the first patient has been enrolled in a multi-center Phase 3 pivotal trial of its lead investigational drug, SD-809 for the treatment of involuntary movements (chorea) associated with Huntington's Disease.
› Verified 4 days ago
| Entity Name | Sound Community Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396700886 PECOS PAC ID: 7517981517 Enrollment ID: O20060117001127 |
News Archive
Alcoholism is a tough addiction to kick. Eventually, most people return to drinking. But some Dutch and German psychological scientists have tested a short-term regime that promises to help alcoholics stay sober. Their study is published in Psychological Science, a journal of the Association of Psychological Science.
A new study shows that concern about infertility resulting from breast cancer therapy influenced treatment decisions in nearly one-third of young patients.
Today's headlines hint that summer's almost over, but the heat will still be on for health reform.
Early testing of an experimental human monoclonal antibody showed a striking benefit in patients with advanced melanoma, say researchers at The University of Texas M. D. Anderson Cancer Center, who presented their findings at the annual meeting of the American Society of Clinical Oncology.
Auspex Pharmaceuticals announced today that the first patient has been enrolled in a multi-center Phase 3 pivotal trial of its lead investigational drug, SD-809 for the treatment of involuntary movements (chorea) associated with Huntington's Disease.
› Verified 4 days ago
| Entity Name | Middlesex Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760451041 PECOS PAC ID: 5092611731 Enrollment ID: O20060912000506 |
News Archive
Alcoholism is a tough addiction to kick. Eventually, most people return to drinking. But some Dutch and German psychological scientists have tested a short-term regime that promises to help alcoholics stay sober. Their study is published in Psychological Science, a journal of the Association of Psychological Science.
A new study shows that concern about infertility resulting from breast cancer therapy influenced treatment decisions in nearly one-third of young patients.
Today's headlines hint that summer's almost over, but the heat will still be on for health reform.
Early testing of an experimental human monoclonal antibody showed a striking benefit in patients with advanced melanoma, say researchers at The University of Texas M. D. Anderson Cancer Center, who presented their findings at the annual meeting of the American Society of Clinical Oncology.
Auspex Pharmaceuticals announced today that the first patient has been enrolled in a multi-center Phase 3 pivotal trial of its lead investigational drug, SD-809 for the treatment of involuntary movements (chorea) associated with Huntington's Disease.
› Verified 4 days ago
| Entity Name | Bhcare, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306042700 PECOS PAC ID: 5193819308 Enrollment ID: O20070919000431 |
News Archive
Alcoholism is a tough addiction to kick. Eventually, most people return to drinking. But some Dutch and German psychological scientists have tested a short-term regime that promises to help alcoholics stay sober. Their study is published in Psychological Science, a journal of the Association of Psychological Science.
A new study shows that concern about infertility resulting from breast cancer therapy influenced treatment decisions in nearly one-third of young patients.
Today's headlines hint that summer's almost over, but the heat will still be on for health reform.
Early testing of an experimental human monoclonal antibody showed a striking benefit in patients with advanced melanoma, say researchers at The University of Texas M. D. Anderson Cancer Center, who presented their findings at the annual meeting of the American Society of Clinical Oncology.
Auspex Pharmaceuticals announced today that the first patient has been enrolled in a multi-center Phase 3 pivotal trial of its lead investigational drug, SD-809 for the treatment of involuntary movements (chorea) associated with Huntington's Disease.
› Verified 4 days ago
| Entity Name | St. Vincent's Multispecialty Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043544489 PECOS PAC ID: 6204977218 Enrollment ID: O20100112000538 |
News Archive
Alcoholism is a tough addiction to kick. Eventually, most people return to drinking. But some Dutch and German psychological scientists have tested a short-term regime that promises to help alcoholics stay sober. Their study is published in Psychological Science, a journal of the Association of Psychological Science.
A new study shows that concern about infertility resulting from breast cancer therapy influenced treatment decisions in nearly one-third of young patients.
Today's headlines hint that summer's almost over, but the heat will still be on for health reform.
Early testing of an experimental human monoclonal antibody showed a striking benefit in patients with advanced melanoma, say researchers at The University of Texas M. D. Anderson Cancer Center, who presented their findings at the annual meeting of the American Society of Clinical Oncology.
Auspex Pharmaceuticals announced today that the first patient has been enrolled in a multi-center Phase 3 pivotal trial of its lead investigational drug, SD-809 for the treatment of involuntary movements (chorea) associated with Huntington's Disease.
› Verified 4 days ago
| Entity Name | Hartford Psychological Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891989026 PECOS PAC ID: 6406178961 Enrollment ID: O20141211001758 |
News Archive
Alcoholism is a tough addiction to kick. Eventually, most people return to drinking. But some Dutch and German psychological scientists have tested a short-term regime that promises to help alcoholics stay sober. Their study is published in Psychological Science, a journal of the Association of Psychological Science.
A new study shows that concern about infertility resulting from breast cancer therapy influenced treatment decisions in nearly one-third of young patients.
Today's headlines hint that summer's almost over, but the heat will still be on for health reform.
Early testing of an experimental human monoclonal antibody showed a striking benefit in patients with advanced melanoma, say researchers at The University of Texas M. D. Anderson Cancer Center, who presented their findings at the annual meeting of the American Society of Clinical Oncology.
Auspex Pharmaceuticals announced today that the first patient has been enrolled in a multi-center Phase 3 pivotal trial of its lead investigational drug, SD-809 for the treatment of involuntary movements (chorea) associated with Huntington's Disease.
› Verified 4 days ago
| Entity Name | Prospect Rockville Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205283538 PECOS PAC ID: 4880988211 Enrollment ID: O20160913001880 |
News Archive
Alcoholism is a tough addiction to kick. Eventually, most people return to drinking. But some Dutch and German psychological scientists have tested a short-term regime that promises to help alcoholics stay sober. Their study is published in Psychological Science, a journal of the Association of Psychological Science.
A new study shows that concern about infertility resulting from breast cancer therapy influenced treatment decisions in nearly one-third of young patients.
Today's headlines hint that summer's almost over, but the heat will still be on for health reform.
Early testing of an experimental human monoclonal antibody showed a striking benefit in patients with advanced melanoma, say researchers at The University of Texas M. D. Anderson Cancer Center, who presented their findings at the annual meeting of the American Society of Clinical Oncology.
Auspex Pharmaceuticals announced today that the first patient has been enrolled in a multi-center Phase 3 pivotal trial of its lead investigational drug, SD-809 for the treatment of involuntary movements (chorea) associated with Huntington's Disease.
› Verified 4 days ago
| Entity Name | Prospect Manchester Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316394638 PECOS PAC ID: 9234423625 Enrollment ID: O20160926000570 |
News Archive
Alcoholism is a tough addiction to kick. Eventually, most people return to drinking. But some Dutch and German psychological scientists have tested a short-term regime that promises to help alcoholics stay sober. Their study is published in Psychological Science, a journal of the Association of Psychological Science.
A new study shows that concern about infertility resulting from breast cancer therapy influenced treatment decisions in nearly one-third of young patients.
Today's headlines hint that summer's almost over, but the heat will still be on for health reform.
Early testing of an experimental human monoclonal antibody showed a striking benefit in patients with advanced melanoma, say researchers at The University of Texas M. D. Anderson Cancer Center, who presented their findings at the annual meeting of the American Society of Clinical Oncology.
Auspex Pharmaceuticals announced today that the first patient has been enrolled in a multi-center Phase 3 pivotal trial of its lead investigational drug, SD-809 for the treatment of involuntary movements (chorea) associated with Huntington's Disease.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Luis Roberto Gonzalez, MD Po Box 390, New London, CT 06320-0390 Ph: (860) 271-4715 | Dr Luis Roberto Gonzalez, MD 21 Montauk Ave, New London, CT 06320-4906 Ph: (860) 439-6400 |
News Archive
Alcoholism is a tough addiction to kick. Eventually, most people return to drinking. But some Dutch and German psychological scientists have tested a short-term regime that promises to help alcoholics stay sober. Their study is published in Psychological Science, a journal of the Association of Psychological Science.
A new study shows that concern about infertility resulting from breast cancer therapy influenced treatment decisions in nearly one-third of young patients.
Today's headlines hint that summer's almost over, but the heat will still be on for health reform.
Early testing of an experimental human monoclonal antibody showed a striking benefit in patients with advanced melanoma, say researchers at The University of Texas M. D. Anderson Cancer Center, who presented their findings at the annual meeting of the American Society of Clinical Oncology.
Auspex Pharmaceuticals announced today that the first patient has been enrolled in a multi-center Phase 3 pivotal trial of its lead investigational drug, SD-809 for the treatment of involuntary movements (chorea) associated with Huntington's Disease.
› Verified 4 days ago
Bilal Hameed, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 194 Howard St Ste 1, New London, CT 06320 Phone: 860-440-0640 Fax: 860-865-2397 | |
Dr. Sherrie Sharp, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 255 Hempstead St, New London, CT 06320 Phone: 860-443-2896 | |
Dr. Henry F Crabbe, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 5 Shaws Cv Ste 207, New London, CT 06320 Phone: 860-444-8877 Fax: 860-444-9660 | |
Dr. Louis Henry Reich, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 292 Montauk Avenue, New London, CT 06320 Phone: 860-443-1200 Fax: 860-442-4488 | |
Dr. Stephen Glenn Vance, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 21 Montauk Ave, New London, CT 06320 Phone: 860-439-6400 Fax: 860-271-4797 | |
Dr. Ammar S Traboulsi, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 41 Fair Harbour Pl, New London, CT 06320 Phone: 860-437-6914 | |
Amy Stevens, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-271-4655 |